2007
DOI: 10.1016/j.thromres.2007.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of reticulated platelets in patients with sickle cell diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
6
0
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 20 publications
2
6
0
1
Order By: Relevance
“…22 The increased level of sPselectin (indicating platelet disturbances) during crisis suggests that it is a transient feature associated with acute events. Notably, platelet expression of P-selectin is raised in the veno-occlusive crisis of SCD, 21 and this supports our finding of raised soluble levels in our patients in crisis. However, in our study, as the increase in NTBI during crisis was not significant, the iron abnormality seems unlikely to contribute, in an acute setting, to raised sP-selectin alone.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…22 The increased level of sPselectin (indicating platelet disturbances) during crisis suggests that it is a transient feature associated with acute events. Notably, platelet expression of P-selectin is raised in the veno-occlusive crisis of SCD, 21 and this supports our finding of raised soluble levels in our patients in crisis. However, in our study, as the increase in NTBI during crisis was not significant, the iron abnormality seems unlikely to contribute, in an acute setting, to raised sP-selectin alone.…”
Section: Discussionsupporting
confidence: 91%
“…This study confirms the presence of raised plasma levels of sP-selectin 9,16,20,21 in SCD. Despite the widely held view that sP-selectin arises almost exclusively from platelets, 7 we acknowledge the possibility that some may arise from an activated endothelium, although some of this evidence is from transgenic sickle mice.…”
Section: Discussionsupporting
confidence: 86%
“…However, a study of 16 patients with steady state sickle cell anemia in the U.K. found decreased mean platelet volume in patients compared with ethnically matched controls (7.6 ± 1.1 vs. 8.4 ± 0.9) (67). Most recently, a study of 89 Brazilian patients with SCD (including patients SC and Sβ-thalassemia) found an increase in the total number of platelets larger than 12 fl, especially in patients with pain crisis, but the percentage of large platelets was not increased (52).Genetic, environmental, and/or technical variations may account for the reported differences in platelet size in patients with SCD. Additional studies of platelet size in humans with SCD, along with appropriate controls, are needed to clarify this issue.…”
Section: Discussionmentioning
confidence: 98%
“…The one parameter suggesting thrombopoietic stress was the increased thiazole orange staining of platelets. An increase in platelets staining with thiazole-orange has been reported in humans with SCD, with the greatest increase in patients during pain crisis (52). Elevated erythropoietin levels in SS mice and patients with SCD may contribute to the increase, since erythropoietin therapy in neonates has been associated with an increase in thiazole orange-staining platelets even without producing an increase in platelet count (60).…”
Section: Discussionmentioning
confidence: 99%
“…Noronha et al [55], demonstrated that patients with sickle cell vasoocclusive crisis had higher circulating RP vs patients in stable phase.…”
Section: Vaso-occlusive Crisis In Sickle Cell Anemiamentioning
confidence: 99%